Nvax Stock Or Ino For Swine Flu
Q: I believe NVAX is oversold on speculation that they might help in a vaccine. Keep in mind that a vaccine will take 60 - 120 days just to create and then marketing will be much greater. Also, government regulators will KILL any attempts for profit on this outbreak. Remember that "greed" is a bad word now a days. I prefer INO as it is under priced and not a "clinical stage" company. It plays a more supportive role.
A: The vaccine has yet to be approved by the Food and Drug Administration, meaning there aren't any chances for the drug to be released for commercial distribution yet. However, in case of a pandemic or outbreak, the government could call on the company to produce the drug on an emergency basis to help with the latest outbreak of swine flu in Mexico and recent cases in the U.S., an analyst from Rodman & Renshaw said. Nvax drug will be made available if this swine flu gets bad, u can believe that. It does not matter whether its FDA Approved or not. Nvax has already contacted the FDA and White House.
Most Popular Articles
- Mechanical Engineering